German drugmaker Merck KGaA said on Thursday it will acquire U.S. biotech firm Bio-Techne for $11.3 billion, its largest deal in over a decade, as it looks to strengthen its life sciences business.

Merck has inaugurated the Merck Global Capability Centre (MGCC) in Electronic City, Bengaluru. The new 17,000-square-metre campus integrates the company’s existing India technology and services ...

Merck & Co. has nixed the phase 2 study of a potential Alzheimer’s disease medicine after the drug underwhelmed in an interim analysis, marking another blow for the pharma’s struggling partner ...

Merck KGaA has committed $50 million to build a new biotech with prolific life science investor Versant Ventures, with the ultimate goal of devouring the NewCo down the line. The new outfit, called ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Drugmakers asked to provide trial details by July 17 Lawmaker says letters sent to five pharma companies Trials in Xinjiang and military hospitals under scrutiny China has overtaken US in early drug ...

Germany's Merck KGaA is poised to increase the size of its life sciences business, which provides tools for research, drug discovery, and manufacturing, with an $11.3 billion deal to acquire US rival ...

Merck offered $73 per share, implying a 24% premium to Wednesday's close Merck expects deal to close by late 2026 or early 2027 Sees about 140 million euros in cost savings by the third year after ...

Germany’s Merck MRK0.07%increase; up pointing triangle KGaA said it struck a deal to buy U.S. life-sciences tools supplier Bio-Techne TECH 0.21%increase; up pointing triangle for $11.3 billion, in an ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

With Merck KGaA’s former electronics business lead Kai Beckmann now at the helm of the entire conglomerate, the new CEO is making his mark with a major outlay to support the company’s life sciences ...

Merck KGaA agreed to buy Bio-Techne Corporation for about $11.3 billion to bolster its life-science business, marking the German pharma and technology group’s biggest acquisition in more than a decade ...